US approval for Innovative Technologies' alginate dressings
This article was originally published in Clinica
UK-based biomaterials developer Innovative Technologies Group has received 510(k) clearance from the US FDA for a range of alginate dressings. The clearance took a mere 17 days and adds alginate dressings to Innovative's approved film and hydrocolloid dressings for sale in the US. The company estimates the US alginate dressings market at about $25 million a year, growing by 25% a year.
You may also be interested in...
Amneal has acquired a majority stake in manufacturer and wholesaler AvKARE, giving the firm access to the “large, complex and growing federal healthcare market.”
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
Execs On The Move: Owens & Minor And MicroPort See Big Departures; Dynatronics CEO Moving To BrainsWay
Owens & Minor finance boss joins drug-delivery device maker Intersect ENT; operations VP at MicroPort joins bioprosthetic heart maker Carmat; Dynatronics CEO will head neuromodulation product firm BrainsWay in January; and more.